Drug intelligence / Profile preview

ClariVein RES + sodium tetradecyl sulfate

Development stage
Unknown
Lead developer
Merit Medical Systems
Modality
Small Molecules
Administration
Intravenous
01

Overview

ClariVein RES is a mechanochemical ablation (MOCA) system developed by Vascular Insights (now part of Merit Medical Systems) for the treatment of chronic venous insufficiency, particularly in the great saphenous vein. The system utilizes a specialized catheter with a rotating wire tip that mechanically disrupts the endothelial lining of the target vessel. Simultaneously, a liquid sclerosant, typically sodium tetradecyl sulfate (STS), is infused through the catheter. The mechanical agitation increases the surface area of the vein wall and enhances the penetration of the sclerosant, leading to rapid protein denaturation, endothelial destruction, and subsequent fibrosis and permanent occlusion of the vein. As a non-thermal, non-tumescent (NTNT) procedure, it eliminates the need for tumescent anesthesia and avoids the risks of thermal nerve injury associated with laser or radiofrequency ablation.

Brand names
ClariVein RESClariVeinSotradecol
Other names
Mechanochemical ablationMOCASTS

Beyond the preview

Go deeper on ClariVein RES + sodium tetradecyl sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ClariVein RES + sodium tetradecyl sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call